PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 12831581

Comments on oocyte cryopreservation.

Fernando Marina·Simón Marina
View original source ↗Export metadata ↓

Abstract

Recently, Robert Winston stated publicly that freezing human oocytes could cause irreparable harm to future generations. In this paper, this affirmation is refuted with arguments and facts. With regard to the low efficacy of the oocyte freezing technique, data are provided on the number of frozen oocytes required to achieve one pregnancy: 100, 17 and 25 in three different papers, compared with 50 fresh oocytes in another. Two recent articles are cited. One shows similar results (pregnancy/cycle) when using frozen oocytes and frozen embryos (17.2 and 18.7% respectively). The other reported birth rates with fresh oocytes (57.9%), frozen embryos (52.9%) and frozen oocytes (45.8%). The legal situation with regard to freezing oocytes in Spain is described, as is the legal uncertainty experienced by the CEFER Reproduction Institute when it began freezing human oocytes for use in assisted reproduction.

Explore related subjects

Birth RateCryopreservationFemaleFertilization in VitroHumansOocytesPregnancyPregnancy RateReproductive Techniques, AssistedSafetySpainSperm Injections, IntracytoplasmicJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Fernando Marina, Simón Marina. 2003. Comments on oocyte cryopreservation.. https://doi.org/10.1016/s1472-6483(10)62157-8

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Primary immunodeficiency diseases in Latin America: the second report of the LAGID registry.

This is the second report on the continuing efforts of LAGID to increase the recognition and registration of patients with primary immunodeficiency diseases in 12 Latin American countries: Argentina, Brazil, Chile, Colombia, Costa Rica, Honduras, Mexico, Panama, Paraguay, Peru, Uruguay, and Venezuela. This report reveals that from a total of 3321 patients registered, the most common form of primary immunodeficiency disease was predominantly antibody deficiency (53.2%) with IgA deficiency reported as the most frequent phenotype. This category was followed by 22.6% other well-defined ID syndromes, 9.5% combined T- and B-cell inmunodeficiency, 8.6% phagocytic disorders, 3.3% diseases of immune dysregulation, and 2.8% complement deficiencies. All countries that participated in the first publication in 1998 reported an increase in registered primary immunodeficiency cases, ranging between 10 and 80%. A comparison of the estimated minimal incidence of X-linked agammaglobulinemia, chronic granulomatous disease, and severe combined immunodeficiency between the first report and the present one shows an increase in the reporting of these diseases in all countries. In this report, the estimated minimal incidence of chronic granulomatous disease was between 0.72 and 1.26 cases per 100,000 births in Argentina, Chile, Costa Rica, and Uruguay and the incidence of severe combined immunodeficiency was 1.28 and 3.79 per 100,000 births in Chile and Costa Rica, respectively. However, these diseases are underreported in other participating countries. In addition to a better diagnosis of primary immunodeficiency diseases, more work on improving the registration of patients by each participating country and by countries that have not yet joined LAGID is still needed.

Birth Rate↗